ETG Lublin Sp. z o.o.

At ETG Lublin Sp. z o.o., clinical research in cardiovascular medicine focuses on people with established cardiovascular disease, high cardiovascular risk, and hypertension. The trials are designed to explore whether new approaches can better prevent serious heart and circulation-related events and improve disease control.

• Evaluating ways to reduce the risk of heart attack, stroke, and cardiovascular death
• Studying treatment options for blood pressure management in higher-risk patients
• Testing new therapies aimed at lowering long-term cardiovascular event risk

This area reflects a strong interest in prevention-focused research, with the site contributing to studies that aim to improve outcomes for patients at risk of major cardiovascular disease complications.

Clinical trials in skin and connective tissue diseases at this site center on venous leg ulcer care. The main goal is to assess whether new wound treatments can support cleaner wound beds, improve debridement, and help advance healing in people living with chronic ulcers.

• Investigating treatment strategies for venous leg ulcers
• Assessing wound debridement and preparation of the wound bed
• Comparing a new wound therapy with placebo to understand effectiveness and safety

This work adds an important wound-care dimension to the research portfolio at ETG Lublin Sp. z o.o., linking practical healing outcomes with broader dermatology and tissue repair research.